Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07NAJ
|
|||
| Former ID |
DAP000131
|
|||
| Drug Name |
Chloroprocaine
|
|||
| Synonyms |
Chloroprocain; Chloroprocainum; Chlorprocaine; Chlorprocainum; Cloroprocaina; Halestyn; Nesacaine; Piocaine; Chloroprocaine [INN]; Chloroprocaine hydrochloride; Nesacaine MPF; Chlor-procaine; Chloroprocaine (INN); Chloroprocainum [INN-Latin]; Cloroprocaina [INN-Spanish]; Nesacaine (TN); Nesacaine-Ce; Nesacaine-MPF (TN); Benzoic acid, 4-amino-2-chloro-, 2-(diethylamino)ethyl ester; 2-(Diethylamino)ethyl 4-amino-2-chlorobenzoate; 2-(Diethylaminoethyl)-4-amino-2-chlorobenzoate; 2-Chloroprocaine; 2-diethylaminoethyl 4-amino-2-chlorobenzoate; 4-amino-2-chlorobenzoic acid 2-(diethylamino)ethyl ester
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Anaesthesia [ICD-11: 9A78.6; ICD-9: 338] | Approved | [1], [2] | |
| Therapeutic Class |
Anesthetics
|
|||
| Company |
Abbott Laboratories
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H19ClN2O2
|
|||
| Canonical SMILES |
CCN(CC)CCOC(=O)C1=C(C=C(C=C1)N)Cl
|
|||
| InChI |
1S/C13H19ClN2O2/c1-3-16(4-2)7-8-18-13(17)11-6-5-10(15)9-12(11)14/h5-6,9H,3-4,7-8,15H2,1-2H3
|
|||
| InChIKey |
VDANGULDQQJODZ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 133-16-4
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
10079, 6867171, 7978920, 8156087, 10506786, 14848393, 29227282, 46508245, 48415759, 49885651, 50737810, 51091980, 57325131, 93581328, 104318307, 126408473, 129457573, 134222419, 134337453, 134974415, 136933656, 137005484, 140603029, 146711553, 160964495, 163192240, 175265449, 178103720, 179225188, 226398150, 249950684, 251916823, 251918062, 252332530
|
|||
| ChEBI ID |
CHEBI:3636
|
|||
| ADReCS Drug ID | BADD_D00438 ; BADD_D00439 | |||
| SuperDrug ATC ID |
N01BA04
|
|||
| SuperDrug CAS ID |
cas=000133164
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7145). | |||
| REF 2 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 040273. | |||
| REF 3 | Inhibition of the Na,K-ATPase of canine renal medulla by several local anesthetics. Pharmacol Res. 2001 Apr;43(4):399-403. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.